1Department of Immunology, School of Medicine,UConn Health, 2Center for Molecular Discovery,University of New Mexico Health Sciences Center, 3Comprehensive Cancer Center,University of New Mexico Health Sciences Center, 4Department of Pathology,University of New Mexico Health Sciences Center, 5Autophagy, Inflammation, & Metabolism (AIM) Center,University of New Mexico
Detta protokoll beskriver en flödescytometribaserad screeningmetod med hög genomströmning för att identifiera småmolekylära läkemedel som hämmar β2-integrinaktivering på humana neutrofiler.
